Pay in 4 interest-free payments of $9.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
This agent may act synergistically with other chemotherapeutic agents
PF04494700
compared to <6 for BIX01294
ABT-199 inhibits the growth of BCL-2–dependent human hematological tumors in vivo and spares human platelets as a single agent or in combination with rituximab and bendamustine
Combining PDMP and GNF-2 eliminated transplanted-CML-T315I-mutants in vivo and dose dependently sensitized primary cells from CML T315I patients to GNF-2-induced proliferation inhibition and apoptosis
GW3965 HCl - CAS# 405911-17-3 size:2mg solid This agent may act synergisticallyGW3965 HCl, CAS No. 405911 17 3, is a liver X receptor agonist. GW3965 represses the production of pro inflammatory cytokines by murine mast cells. GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E. GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro. GW3965 dose dependently regulates lps mediated liver injury and modulates posttranscriptional TNF alpha
US$ 2745.00
US$ 124.50
US$ 122.83
US$ 1000.00
US$ 40.68
US$ 1400.00
US$ 120.00
US$ 189.00
US$ 169.00
US$ 50.63